|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.200 GBX | 0.00% |
|
-7.69% | +5.00% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
Pharmaceutical Products | ||||
Total Assets | 2.3Cr | 1.93Cr | 1.54Cr | 1.02Cr |
Income Tax Expense | - | -91T | -6L | -2L |
CAPEX | -81T | -6L | - | - |
EBT | -23.36L | -47.77L | -45.05L | -59.44L |
D&A | 18T | 26T | 26T | 1L |
Operating Income | - | -49.86L | -50.39L | -63.72L |
Net Income | -23.36L | -46.86L | -39.31L | -57.9L |
Geographical Revenue Distribution History
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
Total Assets | 15.63L | 18.62L | 16.49L | 14.13L |
Total Assets | - | 3L | 3L | 3L |
- Stock Market
- Equities
- POLB Stock
- Financials Poolbeg Pharma PLC
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition